Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

AN ONLINE, RADIATION HARD PROTON ENERGY-RESOLVING SCINTILLATOR STACK FOR LASER-DRIVEN PROTON BUNCHES.

Englbrecht FS, Würl M, Olivari F, Ficorella A, Kreuzer C, Lindner FH, Palma MD, Pancheri L, Betta GD, Schreiber J, Quaranta A, Parodi K.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):291-295. doi: 10.1093/rpd/ncy008.

PMID:
29415243
2.

Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.

Evangelista L, Palma MD, Gregianin M, Nardin M, Roma A, Nicoletto MO, Nardelli GB, Zagonel V.

J Turk Ger Gynecol Assoc. 2015 Aug 6;16(3):137-44. doi: 10.5152/jtgga.2015.15251. eCollection 2015.

3.

Axillary Padding without Drainage after Axillary Lymphadenectomy - a Prospective Study of 299 Patients with Early Breast Cancer.

Garbay JR, Thoury A, Moinon E, Cavalcanti A, Palma MD, Karsenti G, Leymarie N, Sarfati B, Rimareix F, Mazouni C.

Breast Care (Basel). 2012 Jun;7(3):231-235. Epub 2012 Jun 27.

4.

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.

Paraiso KH, Xiang Y, Rebecca VW, Abel EV, Chen YA, Munko AC, Wood E, Fedorenko IV, Sondak VK, Anderson AR, Ribas A, Palma MD, Nathanson KL, Koomen JM, Messina JL, Smalley KS.

Cancer Res. 2011 Apr 1;71(7):2750-60. doi: 10.1158/0008-5472.CAN-10-2954. Epub 2011 Feb 11.

5.

Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma.

Zustovich F, Lombardi G, Pastorelli D, Farina P, Bianco MD, De Zorzi L, Palma MD, Nicoletto O, Zagonel V.

Open Access J Urol. 2011 May 10;3:69-82. doi: 10.2147/OAJU.S7230. Review.

6.

Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatment.

Palma MD, Lombardi G, Donach ME, Borgato L, Zustovich F, Furini L, Nicoletto MO.

Am J Clin Oncol. 2011 Jun;34(3):305-8. doi: 10.1097/COC.0b013e3181e1cb22.

PMID:
20622643
7.

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL.

Cancer Res. 2008 Sep 1;68(17):7006-14. doi: 10.1158/0008-5472.CAN-08-0599. Epub 2008 Aug 14.

8.

Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States.

Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL.

Clin Breast Cancer. 2007 Jun;7(8):627-33.

PMID:
17592676
9.

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.

Guida M, Riccobon A, Biasco G, Ravaioli A, Casamassima A, Freschi A, Palma MD, Galligioni E, Nortilli R, Chiarion-Sileni V, Picozzo J, Romanini A, Nanni O, Ridolfi R; Italian Melanoma Intergroup (IMI).

Melanoma Res. 2006 Aug;16(4):317-23.

PMID:
16845327
10.

Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers.

Indraccolo S, Tisato V, Agata S, Moserle L, Ferrari S, Callegaro M, Persano L, Palma MD, Scaini MC, Esposito G, Fassina A, Nicoletto O, Plebani M, Chieco-Bianchi L, Amadori A, D'Andrea E, Montagna M.

Eur J Cancer. 2006 Jul;42(10):1475-83. Epub 2006 Jun 8.

PMID:
16759848
11.

Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats.

Aller MA, Vara E, Garcia C, Palma MD, Arias JL, Nava MP, Arias J.

Mediators Inflamm. 2005 Jun 9;2005(2):101-11.

12.

Portal hypertension produces an evolutive hepato-intestinal pro- and anti-inflammatory response in the rat.

Palma MD, Aller MA, Vara E, Nava MP, Garcia C, Arias-Diaz J, Balibrea JL, Arias J.

Cytokine. 2005 Aug 7;31(3):213-26.

PMID:
15950486
13.

Chronic portal hypertension in the rat by triple-portal stenosing ligation.

Diéguez B, Aller MA, Nava MP, Palma MD, Arias JL, López L, Arias J.

J Invest Surg. 2002 Nov-Dec;15(6):329-36.

PMID:
12542867
14.

Increased duodenal mucosa infiltration by mast cells in rats with portal hypertension.

Diez-Arias JA, Aller MA, Palma MD, Arias JL, Muñiz E, Sánchez M, Arias J.

Dig Surg. 2001;18(1):34-40.

PMID:
11244257
15.

[Gene therapy in oncology: applications to lung cancer].

Chapiro J, Palma MD, Mignot L, Lemonnier MP, Beaumelou E, Coulet F, Misset JL, Jasmin C.

Rev Mal Respir. 1996 Oct;13(5):467-76. Review. French.

PMID:
8999473

Supplemental Content

Loading ...
Support Center